ASA
AMGN icon

Armstrong Shaw Associates’s Amgen AMGN Stock Holding History

Armstrong Shaw Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-66,830
Closed -$11.1M – 45
2016
Q3 		$11.1M Sell
66,830
-1,719
-3% -$291K 2.77% 21
2016
Q2 		$10.4M Sell
68,549
-73
-0.1% -$11.3K 2.66% 23
2016
Q1 		$10.3M Sell
68,622
-4,298
-6% -$639K 2.66% 21
2015
Q4 		$11.8M Sell
72,920
-2,394
-3% -$376K 2.79% 19
2015
Q3 		$10.4M Buy
75,314
+181
+0.2% +$28.5K 2.53% 23
2015
Q2 		$11.5M Sell
75,133
-607
-0.8% -$97.2K 2.5% 23
2015
Q1 		$12.1M Sell
75,740
-14,354
-16% -$2.26M 2.6% 23
2014
Q4 		$14.4M Sell
90,094
-3,068
-3% -$478K 2.6% 22
2014
Q3 		$13.1M Sell
93,162
-2,514
-3% -$328K 2.38% 24
2014
Q2 		$11.3M Sell
95,676
-55,198
-37% -$6.39M 2.05% 27
2014
Q1 		$18.6M Sell
150,874
-332,249
-69% -$40.3M 2.29% 27
2013
Q4 		$55.1M Buy
483,123
+34,972
+8% +$3.98M 2.04% 28
2013
Q3 		$50.2M Sell
448,151
-4,857
-1% -$527K 2.04% 30
2013
Q2 		$44.7M Buy
+453,008
New +$47M 1.87% 33

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Armstrong Shaw Associates's AMGN Position: Q4 2016 in Review

Armstrong Shaw Associates sold out of Amgen (AMGN) in Q4 2016, closing a stake of 66,830 shares — an estimated $11.1M sold.

Armstrong Shaw Associates first reported a position in AMGN in Q2 2013 and held it in 14 quarters. The position peaked at $55.1M in Q4 2013. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Armstrong Shaw Associates reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Armstrong Shaw Associates sold 66,830 Amgen shares in Q4 2016, an estimated $11.1M.
  • Armstrong Shaw Associates first reported a position in Amgen in Q2 2013 and held it in 14 quarters.
  • Armstrong Shaw Associates's Amgen position peaked at $55.1M in Q4 2013.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Armstrong Shaw Associates's 13F filing for Q4 2016, filed 20 Jan 2017.